DaVita Inc. (LON:0I7E)
London · Delayed Price · Currency is GBP · Price in USD 152.39
+8.46 (5.88%)
Feb 12, 2026, 5:09 PM GMT
DaVita Market Cap
DaVita has a market cap or net worth of 7.06 billion as of February 12, 2026. Its market cap has decreased by -38.18% in one year.
Market Cap
7.06B
Enterprise Value
17.31B
Revenue
10.14B
Ranking
n/a
PE Ratio
12.73
Stock Price
152.39
Market Cap Chart
Since October 31, 1995, DaVita's market cap has increased from 275.69M to 7.06B, an increase of 2,461.16%. That is a compound annual growth rate of 11.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 7.25B | 21.63% |
| Dec 31, 2025 | 5.96B | -39.16% |
| Dec 31, 2024 | 9.80B | 30.38% |
| Dec 29, 2023 | 7.51B | 34.54% |
| Dec 30, 2022 | 5.58B | -34.77% |
| Dec 31, 2021 | 8.56B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |